Last reviewed · How we verify
E. Coli Complicated Appendicitis
Approved treatments
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Merrem · National Institutes of Health Clinical Center (CC)
- Merrem · Pfizer
Meropenem works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Zosyn · Merck Sharp & Dohme B.V.
Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- E. Coli Complicated Appendicitis patent landscape — cliff calendar, originator estates, attackable patents
- E. Coli Complicated Appendicitis treatment landscape brief
- E. Coli Complicated Appendicitis treatment updates RSS
Frequently asked questions about E. Coli Complicated Appendicitis
What drugs treat E. Coli Complicated Appendicitis?
Tracked treatments include Pipracil, Merrem, Zosyn.
What is the treatment for E. Coli Complicated Appendicitis?
Standard treatment for E. Coli Complicated Appendicitis includes Pipracil, Merrem, Zosyn. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: E. Coli Complicated Appendicitis patent cliff · E. Coli Complicated Appendicitis CI report
- Treatment: Pipracil
- Treatment: Merrem · National Institutes of Health Clinical Center (CC)
- Treatment: Merrem · Pfizer
- Treatment: Zosyn · Merck Sharp & Dohme B.V.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing